Liver is endowed with high regenerative activity, so that the tissue regrows in mouse after partial hepatectomy within days. We reason that this requires de novo pyrimidine synthesis to support rapid progression via the cell cycle. We find that suppression of de novo pyrimidine synthesis prevents proliferation in regenerating liver, suppressing liver regrowth. Tracing studies and spatial metabolomics reveal a metabolic shift such that ammonia, normally detoxified to urea in the periportal region under homeostasis, is redirected for generating aspartate and carbamoyl phosphate periportally, and glutamine pericentrally, and these products are utilized as precursors by the de novo pyrimidine synthesis pathway. Our research uncovers a metabolic reprogramming leading to utilization of a toxic byproduct for anabolic pathways that are essential for liver regeneration.

1st Faculty of Medicine Charles University Prague Czech Republic

CIBB Center for Innovative Biomedicine and Biotechnology University of Coimbra Coimbra Portugal

CNC UC Center for Neuroscience and Cell Biology University of Coimbra Coimbra Portugal

College of Pharmacy Natural Product Research Institute Seoul National University Seoul Korea

Faculty of Science Charles University Prague Czech Republic

Faculty of Science Palacký University Olomouc Czech Republic

General University Hospital Prague Czech Republic

Institute of Biotechnology Czech Academy of Sciences Prague West Czech Republic

Institute of Microbiology Czech Academy of Sciences Prague Czech Republic

Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Czech Republic

Institute of Physiology Czech Academy of Sciences Prague Czech Republic

Malaghan Institute of Medical Research Kelburn Wellington New Zealand

PDBEB Doctoral Programme in Experimental Biology and Biomedicine Institute of Interdisciplinary Research University of Coimbra Coimbra Portugal

School of Pharmacy and Medical Science Griffith University Southport Qld Australia

Worcester Chan Medical School University of Massachusetts Cambridge MA USA

Zobrazit více v PubMed

Du, Y. et al. Mouse models of liver parenchyma injuries and regeneration. PubMed DOI PMC

Michalopoulos, G. K. & DeFrances, M. C. Liver regeneration. PubMed DOI

Fausto, N., Campbell, J. S. & Riehle, K. J. Liver regeneration. PubMed DOI

Michalopoulos, G. K. & Bhushan, B. Liver regeneration: biological and pathological mechanisms and implications. PubMed DOI

Tamori, Y. & Deng, W. M. Tissue repair through cell competition and compensatory cellular hypertrophy in postmitotic epithelia. PubMed DOI PMC

Diril, M. K. et al. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. PubMed DOI PMC

Locasale, J. W. & Cantley, L. C. Metabolic flux and the regulation of mammalian cell growth. PubMed DOI PMC

Caldez, M. J. et al. Metabolic remodeling during liver regeneration. PubMed DOI

Tan, V. W. T. et al. SLAM-ITseq identifies that Nrf2 induces liver regeneration through the pentose phosphate pathway. PubMed DOI

Huang, J. S. & Rudnick, D. A. Elucidating the metabolic regulation of liver regeneration. PubMed DOI PMC

Huppert, S. S. & Schwartz, R. E. Multiple facets of cellular homeostasis and regeneration of the mammalian liver. PubMed DOI PMC

Miettinen, T. P. & Björklund, M. Mitochondrial function and cell size: an allometric relationship. PubMed DOI

Mlettinen, T. P. et al. Identification of transcriptional and metabolic programs related to mammalian cell size. PubMed DOI PMC

Tan, A. S. et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. PubMed DOI

Dong, L. F. et al. Mitochondria on the move: Horizontal mitochondrial transfer in disease and health. PubMed PMC

Bajzikova, M. et al. Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient cancer cells. PubMed DOI PMC

Martins, P. N., Theruvath, T. P. & Neuhaus, P. Rodent models of partial hepatectomies. PubMed DOI

Christian, S. et al. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. PubMed DOI

Sykes, D. B. et al. Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia. PubMed DOI PMC

Salic, A. & Mitchison, T. J. A chemical method for fast and sensitive detection of DNA synthesis. PubMed DOI PMC

Santos, A. A. et al. Spatial metabolomics and its application in the liver. PubMed DOI PMC

Russell, J. O. & Camargo, F. D. Hippo signalling in the liver: role in development, regeneration and disease. PubMed DOI PMC

Zarrinpar, A. & Busuttil, R. W. Liver transplantation: past, present and future. PubMed DOI

Verma, A. K., Sharma, A., Subramaniyam, N. & Gandhi, C. R. Augmenter of liver regeneration: Mitochondrial function and steatohepatitis. PubMed DOI

Fausto, N., Brandt, J. T. & Kesner, L. Possible interactions between the urea cycle and synthesis of pyrimidines and polyamines in regenerating liver. PubMed

Mayer, D. et al. Expression of key enzymes of purine and pyrimidine metabolism in a hepatocyte-derived cell-line at different phases of the growth-cycle. PubMed DOI PMC

Usami, M. & Saitoh, Y. The effect of a nucleotide-nucleoside solution on hepatic regeneration in rats after partial hepatectomy and in primary monolayer culture of hepatocytes. PubMed DOI

Boukalova, S. et al. Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer. PubMed

Brown, K. K., Spinelli, J. B., Asara, J. M. & Toker, A. Adaptive reprogramming of De novo pyrimidine synthesis is a metabolic vulnerability in triple-negative breast cancer. PubMed DOI PMC

Yang, C. Z. et al. De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence. PubMed DOI

Paluschinski, M. et al. Characterization of the scavenger cell proteome in mouse and rat liver. PubMed DOI

Brusilow, S. W. & Maestri, N. E. Urea cycle disorders: diagnosis, pathophysiology, and therapy. PubMed DOI

Bartl, M. et al. Optimality in the zonation of ammonia detoxification in rodent liver. PubMed DOI

Spinelli, J. B. et al. Metabolic recycling of ammonia PubMed DOI PMC

Lee, J. S. et al. Urea cycle dysregulation generates clinically relevant genomic and biochemical signatures. PubMed DOI PMC

Rabinovich, S. et al. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. PubMed DOI PMC

Matsumoto, S. et al. Urea cycle disorders-update. PubMed DOI

Grompe, M., Jones, S. N. & Caskey, C. T. Molecular-detection and correction of ornithine transcarbamylase deficiency. PubMed DOI

Hosseini, M. et al. Energy metabolism rewiring precedes UVB-induced primary skin tumor formation. PubMed DOI

Moriyama, M. et al. Decreased ureagenesis from alanine, but not from ammonia and glutamine, in the perfused rat liver after partial hepatectomy. PubMed DOI

Kim, J. et al. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. PubMed DOI PMC

Helman, G., Pacheco-Colón, I. & Gropman, A. L. The urea cycle disorders. PubMed DOI

Kolářová, L. et al. Clusters of monoisotopic elements for calibration in (TOF) mass spectrometry. PubMed DOI

Strohalm, M., Kavan, D., Novák, P., Volný, M. & Havlícek, V. mMass 3: a cross-platform software environment for precise analysis of mass spectrometric data. PubMed DOI

Yin, S., Kabashima, T., Zhu, Q., Shibata, T. & Kai, M. Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker. PubMed DOI PMC